# Evaluation of the Jarvik 2000 Left Ventricular Assist System With Post-Auricular Connector--Destination Therapy Study

Study · id `cardio:ct-nct01627821` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01627821](<https://clinicaltrials.gov/study/NCT01627821>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01627821

Browse, organ or system: Heart  
Browse, condition area: Heart failure  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 350 participants.

## Technical summary

Registry record NCT01627821. Randomized; no masking; primary purpose treatment. Start 2013-02 (registry gives no type); primary completion 2025-03 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 350 participants (planned count; ClinicalTrials.gov record NCT01627821, source copy `cardio:ctgov-nct01627821-2024-03-20`, retrieved 2026-10-26)
- Start date: 2013-02 (registry gives no type) (ClinicalTrials.gov record NCT01627821, source copy `cardio:ctgov-nct01627821-2024-03-20`, retrieved 2026-10-26)
- Primary completion: 2025-03 (anticipated) (ClinicalTrials.gov record NCT01627821, source copy `cardio:ctgov-nct01627821-2024-03-20`, retrieved 2026-10-26)
- Completion: 2025-03 (anticipated) (ClinicalTrials.gov record NCT01627821, source copy `cardio:ctgov-nct01627821-2024-03-20`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT01627821, source copy `cardio:ctgov-nct01627821-2024-03-20`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01627821-2024-03-20`, retrieved 2026-10-26)

## The registry's words

- Brief title: Evaluation of the Jarvik 2000 Left Ventricular Assist System With Post-Auricular Connector--Destination Therapy Study
- Condition: Heart Failure
- Intervention (Device): Jarvik 2000 VAS
- Intervention (Device): HeartMate II
- Lead sponsor: Jarvik Heart, Inc.
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Heart failure (`cardio:heart-failure`)

## Provenance

Content hash: 57c27aa534e85135e17eef5f3fbac274a88e25c0433784573a8ab4c413fc0ff6
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
